Publication Information

{'id': 'https://openalex.org/W2328313486', 'doi': 'https://doi.org/10.2147/btt.s96982', 'title': 'Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers', 'display_name': 'Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers', 'publication_year': 2016, 'publication_date': '2016-04-01', 'ids': {'openalex': 'https://openalex.org/W2328313486', 'doi': 'https://doi.org/10.2147/btt.s96982', 'mag': '2328313486', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27099470', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/4824281'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/btt.s96982', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=29690', 'source': {'id': 'https://openalex.org/S177732258', 'display_name': 'Biologics', 'issn_l': '1177-5475', 'issn': ['1177-5475', '1177-5491'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.dovepress.com/getfile.php?fileID=29690', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5108623508', 'display_name': 'Juha Laine', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I189718659', 'display_name': 'Pfizer (United Kingdom)', 'ror': 'https://ror.org/04x4v8p40', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I189718659']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Juha Laine', 'raw_affiliation_strings': ['Pfizer Oy, Helsinki,'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Oy, Helsinki,', 'institution_ids': ['https://openalex.org/I189718659']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050624270', 'display_name': 'Kari Puolakka', 'orcid': 'https://orcid.org/0000-0003-1307-7421'}, 'institutions': [{'id': 'https://openalex.org/I3132474087', 'display_name': 'Karelia University of Applied Sciences', 'ror': 'https://ror.org/00db2vc28', 'country_code': 'FI', 'type': 'education', 'lineage': ['https://openalex.org/I3132474087']}], 'countries': ['FI'], 'is_corresponding': False, 'raw_author_name': 'Kari Puolakka', 'raw_affiliation_strings': ['Department of Medicine, South Karelia, Finland'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicine, South Karelia, Finland', 'institution_ids': ['https://openalex.org/I3132474087']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039203795', 'display_name': 'Sakari Jokiranta', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Sakari Jokiranta', 'raw_affiliation_strings': ['Research Programs Unit, Immunobiology,', 'United Medix Laboratories Ltd, Espoo,'], 'affiliations': [{'raw_affiliation_string': 'Research Programs Unit, Immunobiology,', 'institution_ids': []}, {'raw_affiliation_string': 'United Medix Laboratories Ltd, Espoo,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058020478', 'display_name': 'Kari K. Eklund', 'orcid': 'https://orcid.org/0000-0002-5870-4663'}, 'institutions': [{'id': 'https://openalex.org/I2800394112', 'display_name': 'Helsinki University Hospital', 'ror': 'https://ror.org/02e8hzf44', 'country_code': 'FI', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800394112', 'https://openalex.org/I4210166427']}, {'id': 'https://openalex.org/I133731052', 'display_name': 'University of Helsinki', 'ror': 'https://ror.org/040af2s02', 'country_code': 'FI', 'type': 'education', 'lineage': ['https://openalex.org/I133731052']}], 'countries': ['FI'], 'is_corresponding': False, 'raw_author_name': 'Kari Eklund', 'raw_affiliation_strings': ['Department of Rheumatology, University of Helsinki,', 'Helsinki University Central Hospital, Helsinki,'], 'affiliations': [{'raw_affiliation_string': 'Helsinki University Central Hospital, Helsinki,', 'institution_ids': ['https://openalex.org/I2800394112']}, {'raw_affiliation_string': 'Department of Rheumatology, University of Helsinki,', 'institution_ids': ['https://openalex.org/I133731052']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5047059121', 'display_name': 'Merja Väkeväinen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I189718659', 'display_name': 'Pfizer (United Kingdom)', 'ror': 'https://ror.org/04x4v8p40', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I189718659']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Merja Väkeväinen', 'raw_affiliation_strings': ['Pfizer Oy, Helsinki,'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Oy, Helsinki,', 'institution_ids': ['https://openalex.org/I189718659']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2320, 'currency': 'USD', 'value_usd': 2320, 'provenance': 'doaj'}, 'apc_paid': {'value': 2320, 'currency': 'USD', 'value_usd': 2320, 'provenance': 'doaj'}, 'fwci': 3.045, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 27, 'citation_normalized_percentile': {'value': 0.999852, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': None, 'issue': None, 'first_page': '67', 'last_page': '67'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/therapeutic-drug-monitoring', 'display_name': 'Therapeutic Drug Monitoring', 'score': 0.674194}], 'concepts': [{'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.954443}, {'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.9523829}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.87386394}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.86703086}, {'id': 'https://openalex.org/C2780272996', 'wikidata': 'https://www.wikidata.org/wiki/Q1261151', 'display_name': 'Therapeutic drug monitoring', 'level': 3, 'score': 0.674194}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.5599338}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.545882}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.45978338}, {'id': 'https://openalex.org/C2777077863', 'wikidata': 'https://www.wikidata.org/wiki/Q170990', 'display_name': 'Arthritis', 'level': 2, 'score': 0.42872757}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.37701932}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.3250258}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3056089}], 'mesh': [], 'locations_count': 5, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/btt.s96982', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=29690', 'source': {'id': 'https://openalex.org/S177732258', 'display_name': 'Biologics', 'issn_l': '1177-5475', 'issn': ['1177-5475', '1177-5491'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc4824281', 'pdf_url': 'https://europepmc.org/articles/pmc4824281?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.dovepress.com/cost-effectiveness-of-routine-measuring-of-serum-drug-concentrations-a-peer-reviewed-article-BTT', 'pdf_url': 'https://www.dovepress.com/article/download/26258', 'source': {'id': 'https://openalex.org/S4306401012', 'display_name': 'Dove Medical Press (Taylor and Francis Group)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'repository'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824281', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27099470', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/btt.s96982', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=29690', 'source': {'id': 'https://openalex.org/S177732258', 'display_name': 'Biologics', 'issn_l': '1177-5475', 'issn': ['1177-5475', '1177-5491'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 19, 'referenced_works': ['https://openalex.org/W1517981661', 'https://openalex.org/W1964449182', 'https://openalex.org/W2017883234', 'https://openalex.org/W2073797451', 'https://openalex.org/W2079590652', 'https://openalex.org/W2085318733', 'https://openalex.org/W2085411350', 'https://openalex.org/W2101168807', 'https://openalex.org/W2110732019', 'https://openalex.org/W2111713621', 'https://openalex.org/W2122404129', 'https://openalex.org/W2125389744', 'https://openalex.org/W2128270329', 'https://openalex.org/W2141395406', 'https://openalex.org/W2145573746', 'https://openalex.org/W2148201023', 'https://openalex.org/W2149065814', 'https://openalex.org/W2150944237', 'https://openalex.org/W2417737666'], 'related_works': ['https://openalex.org/W4293536498', 'https://openalex.org/W3149869290', 'https://openalex.org/W3000540054', 'https://openalex.org/W2755604283', 'https://openalex.org/W2587090798', 'https://openalex.org/W2566490068', 'https://openalex.org/W2552612566', 'https://openalex.org/W2352867790', 'https://openalex.org/W2052175477', 'https://openalex.org/W1588288904'], 'abstract_inverted_index': {'Monitoring': [0], 'of': [1, 8, 12, 22, 29, 41, 54, 62, 89, 112, 132, 138, 149, 164, 188, 209, 232, 251], 'anti-drug': [2], 'antibodies': [3], '(ADAbs)': [4], 'or': [5, 70, 80, 169], 'serum': [6], 'concentrations': [7, 102], 'biologicals': [9], 'in': [10, 26, 82, 105, 130, 144, 160, 193, 228, 241, 258, 266], 'treatment': [11, 66, 184, 226], 'rheumatoid': [13, 83], 'arthritis': [14], 'could': [15], 'provide': [16], 'an': [17], 'explanation': [18], 'for': [19, 180], 'a': [20, 48, 94, 194, 235], 'loss': [21], 'efficacy': [23], 'and': [24, 64, 76, 85, 100, 114, 121, 136, 147, 153, 162, 211, 254], 'help': [25], 'the': [27, 60, 127, 182, 204, 206, 217, 221, 225, 263], 'choice': [28], 'subsequent': [30], 'medication.': [31], 'Current': [32], 'clinical': [33, 189, 243, 259], 'practices': [34], 'do': [35], 'not': [36, 81], 'generally': [37], 'include': [38], 'such': [39, 91], 'monitoring': [40, 92, 110, 174, 222, 250], 'tumor': [42], 'necrosis': [43], 'factor': [44], '(TNF)-α': [45], 'blockers': [46], 'on': [47, 93, 98, 119], 'routine': [49, 95, 249], 'basis.': [50, 96], 'The': [51, 173], 'main': [52], 'aims': [53], 'this': [55], 'study': [56, 246], 'were': [57, 103, 142, 158, 176], 'to': [58, 86, 216], 'estimate': [59], 'probabilities': [61, 179], 'optimal': [63, 183], 'nonoptimal': [65], 'decisions': [67], 'if': [68], 'infliximab': [69, 170], 'adalimumab': [71, 120, 168], 'drug': [72, 252], 'trough': [73], 'level': [74, 253], '(DL)': [75], 'ADAbs': [77, 101, 141, 157, 212, 255], 'are': [78], 'tested': [79], 'arthritis,': [84], 'model': [87], 'cost-effectiveness': [88], 'performing': [90], 'Data': [97], 'DLs': [99, 210], 'obtained': [104], 'Finland': [106], 'from': [107, 117, 134, 151], 'clinically': [108], 'requested': [109], 'analyses': [111], '486': [113], '1,137': [115], 'samples': [116, 133, 150], 'patients': [118], 'infliximab,': [122], 'respectively.': [123, 156, 172], 'DL': [124], 'was': [125, 191, 213], 'within': [126], 'target': [128], 'range': [129], '42%': [131], 'adalimumab-': [135, 152], '50.4%': [137], 'infliximab-treated': [139, 154], 'patients.': [140, 202], 'detected': [143], 'approximately': [145], '20%': [146], '13.5%': [148], 'patients,': [155, 234], 'found': [159], '52.3%': [161], '41.3%': [163], 'those': [165], 'with': [166, 199], 'low': [167], 'DLs,': [171], 'data': [175], 'incorporated': [177], 'into': [178], 'making': [181], 'decision.': [185], 'Economic': [186], 'impact': [187], 'decision-making': [190, 264], 'modeled': [192], 'short-term': [195], '(3-6': [196], 'months)': [197], 'scenario': [198, 219], '100': [200, 233], 'hypothetical': [201], 'In': [203], 'model,': [205], 'combined': [207], 'measurement': [208], 'cost-saving': [214], 'compared': [215], 'nontesting': [218], 'when': [220], 'results': [223], 'affected': [224], 'decision': [227], 'at': [229], 'least': [230], '2-5': [231], 'proportion': [236], 'which': [237], 'is': [238, 256], 'easily': [239], 'exceeded': [240], 'real-life': [242], 'practice.': [244], 'This': [245], 'indicates': [247], 'that': [248], 'cost-beneficial': [257], 'practice,': [260], 'thereby': [261], 'improving': [262], 'process': [265], 'using': [267], 'TNF-α': [268], 'blockers.': [269]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2328313486', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 5}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 5}, {'year': 2018, 'cited_by_count': 6}, {'year': 2017, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 1}], 'updated_date': '2024-12-08T21:11:22.889845', 'created_date': '2016-06-24'}